Didier Samuel

Didier Samuel

Auto-generated profile, based on publicly available information

Didier Samuel

APHP, Hôpital Paul Brousse, Centre Hépato-Biliaire, Unité Inserm 1193, Université Paris-Saclay, Villejuif

Research Focus & Metrics

Academic Career Length

40Years (1987-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2014 in Journal of Hepatology
Verified
Journal Article
Closed access
RJRajiv Jalan
Rajiv Jalan
FSFaouzi Saliba
Faouzi Saliba
MPMarco Pavesi
Marco Pavesi
AAAlex Amoros
Alex Amoros
RMRichard Moreau
Richard Moreau
CCCANONIC study investigators of the EASL-CLIF Consortium
CANONIC study investigators of the EASL-CLIF Consortium

20 November 2008 in Hepatology International
Verified
Journal Article
Open access
PDF file
SSShiv Kumar Sarin
Shiv Kumar Sarin
AKAshish Kumar
Ashish Kumar
JAJohn A. Almeida
John A. Almeida
YCYogesh Kumar Chawla
Yogesh Kumar Chawla
SFSheung Tat Fan
Sheung Tat Fan
MYMan-Fung Yuen
Man-Fung Yuen
The Asian Pacific Association for the Study of the Liver (APASL) set up a working party on acute-on-chronic liver failure (ACLF) in 2004, with a mandate to develop consensus guidelines on various aspects of ACLF relevant to disease patterns and clinical practice in the Asia-Pacific region. Experts predominantly from the Asia–Pacific region constituted this working party and were requested to identify different issues of ACLF and develop the consensus guidelines. A 2-day meeting of the working party was held on January 22–23, 2008, at New Delhi, India, to discuss and finalize the consensus statements. Only those statements that were unanimously approved by the experts were accepted. These statements were circulated to all the experts and subsequently presented at the Annual Conference of the APASL at Seoul, Korea, in March 2008. The consensus statements along with relevant background information are presented in this review.

1 October 2008 in Journal of Hepatology
Verified
Journal Article
Closed access
GRGiovanni Raimondo
Giovanni Raimondo
JAJean-Pierre Allain
Jean-Pierre Allain
Maurizia Rossana BrunettoMaurizia Rossana Brunetto
Maurizia Rossana Brunetto
MBMarie-Annick Buendia
Marie-Annick Buendia
DCDing-Shinn Chen
Ding-Shinn Chen
Fabien ZoulimFabien Zoulim
Fabien Zoulim

26 September 2014 in Hepatology International
Verified
Journal Article
Open access
PDF file
SSShiv Kumar Sarin
Shiv Kumar Sarin
CKChandan Kumar Kedarisetty
Chandan Kumar Kedarisetty
ZAZaigham Abbas
Zaigham Abbas
DADeepak Amarapurkar
Deepak Amarapurkar
CBChhagan Bihari
Chhagan Bihari
TPThe Apasl Aclf Working Party
The Apasl Aclf Working Party
The first consensus report of the working party of the Asian Pacific Association for the Study of the Liver (APASL) set up in 2004 on acute-on-chronic liver failure (ACLF) was published in 2009. Due to the rapid advancements in the knowledge and available information, a consortium of members from countries across Asia Pacific, “APASL ACLF Research Consortium (AARC),” was formed in 2012. A large cohort of retrospective and prospective data of ACLF patients was collated and followed up in this data base. The current ACLF definition was reassessed based on the new AARC data base. These initiatives were concluded on a 2-day meeting in February 2014 at New Delhi and led to the development of the final AARC consensus. Only those statements which were based on the evidence and were unanimously recommended were accepted. These statements were circulated again to all the experts and subsequently presented at the annual conference of the APASL at Brisbane, on March 14, 2014. The suggestions from the delegates were analyzed by the expert panel, and the modifications in the consensus were made. The final consensus and guidelines document was prepared. After detailed deliberations and data analysis, the original proposed definition was found to withstand the test of time and identify a homogenous group of patients presenting with liver failure. Based on the AARC data, liver failure grading, and its impact on the "Golden therapeutic Window," extra-hepatic organ failure and development of sepsis were analyzed. New management options including the algorithms for the management of coagulation disorders, renal replacement therapy, sepsis, variceal bleed, antivirals, and criteria for liver transplantation for ACLF patients were proposed. The final consensus statements along with the relevant background information are presented here.

1 June 2018 in Journal of Hepatology
Verified
Journal Article
Closed access
EMEleonora De Martin
Eleonora De Martin
Jean Marie MichotJean Marie Michot
Jean Marie Michot
BPBarbara Papouin
Barbara Papouin
SCStéphane Champiat
Stéphane Champiat
CMChristine Mateus
Christine Mateus
DSDidier Samuel
Didier Samuel

1 September 2013 in Journal of Hepatology
Verified
Journal Article
Closed access
CHChristophe Hézode
Christophe Hézode
HFHélène Fontaine
Hélène Fontaine
CDCéline Dorival
Céline Dorival
DLDominique Larrey
Dominique Larrey
Fabien ZoulimFabien Zoulim
Fabien Zoulim
JBJean-Pierre Bronowicki
Jean-Pierre Bronowicki